NCT01181843

Brief Summary

This study is designed to determine the incidence and severity of respiratory depression in elective cesarean section patients who have received a spinal or epidural narcotic called duramorph for management of postoperative pain. A monitoring device called a capnograph as well as a device called a pulse oximeter is placed on the patient once in the recovery room after delivery. The capnograph monitors the carbon dioxide level that the patient breathes out as well as their respiratory rate. The pulse oximeter is a device that is taped on the patient's finger and measures their oxygen saturation level. The monitoring is maintained for 18-24 hours after surgery.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jul 2010

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2010

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

August 12, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

August 13, 2010

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2014

Completed
Last Updated

November 8, 2017

Status Verified

February 1, 2017

Enrollment Period

3.9 years

First QC Date

August 12, 2010

Last Update Submit

November 6, 2017

Conditions

Keywords

postoperative pain managementrespiratory depressioncapnographyduramorph

Outcome Measures

Primary Outcomes (1)

  • RESPIRATORY DEPRESSION

    RESPIRATORY DEPRESSION OBSERVATION ONLY OF CURRENT PRACTICES, DOES NOT INVOLVE TREATMENT

    24 HOURS

Study Arms (1)

Cesearean sections receiving duramorph

Eligibility Criteria

Age18 Years - 55 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

subjects having an elective cesearean section and having as their anesthetic either a spinal or epidural and receiving duramorph

You may qualify if:

  • Are female \>= 18 years of age and \<=55 years of age with ASA class I-III
  • Schedule for cesarean surgery
  • Are willing and able to sign informed consent form for this study
  • Are willing and able to follow the instruction in this study protocol

You may not qualify if:

  • Have known contraindication/allergy to neuraxial anesthesia or morphine.
  • Have an ASA class \> III
  • Age \> 55 years

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Forsyth Medical Center-Dept of OB Anesthesia

Winston-Salem, North Carolina, 27103, United States

Location

MeSH Terms

Conditions

Respiratory InsufficiencyPain, Postoperative

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • Peter Pan, MD

    Wake Forest University Health Sciences

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 12, 2010

First Posted

August 13, 2010

Study Start

July 1, 2010

Primary Completion

June 1, 2014

Study Completion

June 1, 2014

Last Updated

November 8, 2017

Record last verified: 2017-02

Locations